Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, Verbee M, Unglaub JM, Thol F, Krause S, Haenel M, Neuerburg C, Vucinic V, Jehn CF, Severmann J, Wass M, Fransecky L, Chemnitz J, Holtick U, Schaefer-Eckart K, Schroeder J, Kraus S, Krueger W, Kaiser U, Scholl S, Koch K, Henning L, Kobbe G, Haas R, Alakel N, Roehnert MA, Sockel K, Hanoun M, Platzbecker U, Holderried TAW, Morgner A, Heuser M, Sauer T, Goetze KS, Wagner-Drouet E, Doehne K, Doehner H, Schliemann C, Schetelig J, Bornhaeuser M, Germing U, Schroeder T, Middeke JM (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Conference Proceedings Title: BLOOD
DOI: 10.1182/blood-2021-153440
APA:
Rautenberg, C., Stoelzel, F., Roellig, C., Stelljes, M., Gaidzik, V., Lauseker, M.,... Middeke, J.M. (2021). Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia. In BLOOD. WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Rautenberg, Christina, et al. "Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2021.
BibTeX: Download